rethinkPeptides Search
Menu
Study breakdown

Head-to-Head: Which Natriuretic Peptide Best Predicts Outcomes in Chagas Heart Disease?

evidence
The takeaway

Direct comparison of BNP, NT-proBNP, and NT-proANP for Chagas disease cardiac prognosis found NT-proBNP was the strongest predictor of adverse cardiovascular outcomes in this neglected tropical disease.

Key finding

Direct comparison of BNP, NT-proBNP, and NT-proANP for Chagas disease cardiac prognosis found NT-proBNP was the strongest predictor of adverse cardiov

What the researchers found

Direct comparison of BNP, NT-proBNP, and NT-proANP for Chagas disease cardiac prognosis found NT-proBNP was the strongest predictor of adverse cardiovascular outcomes in this neglected tropical disease.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2009.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Head-to-Head: Which Natriuretic Peptide Best Predicts Outcomes in Chagas Heart Disease?
What was found?
Direct comparison of BNP, NT-proBNP, and NT-proANP for Chagas disease cardiac prognosis found NT-proBNP was the strongest predictor of adverse cardiovascular outcomes in this neglected tropical disease.

Read the original research

Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides.

Congestive heart failure (Greenwich, Conn.), 15(2), 75-81

Citation

Moreira, Maria da Consolação V; Wang, Yong; Heringer-Walther, Silvia; Wessel, Niels; Walther, Thomas. (2009). Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides.. Congestive heart failure (Greenwich, Conn.), 15(2), 75-81. https://doi.org/10.1111/j.1751-7133.2009.00051.x